- Home
- RDWR vs ARQT Comparison
RDWR vs ARQT Comparison
Compare RDWR & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDWR
- ARQT
- Stock Information
- Founded
- RDWR 1996
- ARQT 2016
- Country
- RDWR Israel
- ARQT United States
- Employees
- RDWR N/A
- ARQT N/A
- Industry
- RDWR EDP Services
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- RDWR Technology
- ARQT Health Care
- Exchange
- RDWR Nasdaq
- ARQT Nasdaq
- Market Cap
- RDWR 973.0M
- ARQT 1.1B
- IPO Year
- RDWR 1999
- ARQT 2020
- Fundamental
- Price
- RDWR $22.58
- ARQT $14.99
- Analyst Decision
- RDWR Buy
- ARQT Strong Buy
- Analyst Count
- RDWR 2
- ARQT 4
- Target Price
- RDWR $30.00
- ARQT $15.50
- AVG Volume (30 Days)
- RDWR 156.2K
- ARQT 2.2M
- Earning Date
- RDWR 02-05-2025
- ARQT 11-06-2024
- Dividend Yield
- RDWR N/A
- ARQT N/A
- EPS Growth
- RDWR N/A
- ARQT N/A
- EPS
- RDWR N/A
- ARQT N/A
- Revenue
- RDWR $266,880,999.00
- ARQT $138,708,000.00
- Revenue This Year
- RDWR $6.66
- ARQT $208.32
- Revenue Next Year
- RDWR $6.65
- ARQT $48.56
- P/E Ratio
- RDWR N/A
- ARQT N/A
- Revenue Growth
- RDWR N/A
- ARQT 182.84
- 52 Week Low
- RDWR $15.71
- ARQT $2.60
- 52 Week High
- RDWR $24.76
- ARQT $15.77
- Technical
- Relative Strength Index (RSI)
- RDWR 44.68
- ARQT 67.53
- Support Level
- RDWR $21.93
- ARQT $12.66
- Resistance Level
- RDWR $23.83
- ARQT $15.02
- Average True Range (ATR)
- RDWR 0.70
- ARQT 1.11
- MACD
- RDWR -0.18
- ARQT 0.14
- Stochastic Oscillator
- RDWR 26.10
- ARQT 78.92
About RDWR Radware Ltd.
Radware Ltd provides cyber security and application delivery solutions. The company provides solutions for cloud, on-premises, and software-defined data centers (SDDC). The solutions of the company secure the digital experience by providing infrastructure, application, and network protection and availability services to enterprises globally. The business segments of the company are Radware's Core Business and The Hawks' Business. The company derives maximum revenue from Radware's Core Business. The company generates maximum revenue from the United States.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.